
Sign up to save your podcasts
Or
In the intricate and occasionally humorous world of medical discoveries, phosphodiesterase type 5 (PDE5) inhibitors stand out as a particularly fortunate accident. Originally developed in the late 1980s for treating angina—a common heart condition characterized by chest pain—these compounds initially failed to significantly improve cardiac symptoms.
In the intricate and occasionally humorous world of medical discoveries, phosphodiesterase type 5 (PDE5) inhibitors stand out as a particularly fortunate accident. Originally developed in the late 1980s for treating angina—a common heart condition characterized by chest pain—these compounds initially failed to significantly improve cardiac symptoms.